David L Cutler


Ontology type: schema:Person     


Person Info

NAME

David L

SURNAME

Cutler

Publications in SciGraph latest 50 shown

  • 2013-12 Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2013-10 Preladenant, a selective adenosine A2A receptor antagonist, is not associated with QT/QTc prolongation in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-11 Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-11 Vorapaxar, an oral PAR-1 receptor antagonist, does not affect the pharmacokinetics and pharmacodynamics of warfarin in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-07 Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-03 No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-03 Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2011-06 Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis C in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2011-05 Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2011-02 Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2010-03 Evaluation of the exposure equivalence of oral versus intravenous temozolomide in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2005-02 Population pharmacokinetic (PPK) analysis of pegylated interferon alfa‐2B (PEG‐Intron) in patients with chronic myelogenous leukemia (CML) in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-02 Pharmacokinetics (PK) of lonafarnib (L), a farnesyl protein transferase inhibitor in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-02 Effects of age and gender on the pharmacokinetics of lonafarnib (L) following a single oral dose in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-04 Marked inactivation of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules in BRITISH JOURNAL OF CANCER
  • 2003-02 Reduced effect of food on the pharmacokinetics of lonafarnib following multiple oral doses in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2000-10 Population Pharmacokinetics of Temozolomide in Cancer Patients in PHARMACEUTICAL RESEARCH
  • 2000-01 In vivo effects of interleukin‐10 on human cytochrome P450 activity in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1999-11 Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies in BRITISH JOURNAL OF CANCER
  • 1999-09 Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-03 Pharmacoimmunodynamic interactions of interleukin‐10 and prednisone in healthy volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1998-12 Pharmacokinetics and Leukocyte Responses of Recombinant Human Interleukin-10 in PHARMACEUTICAL RESEARCH
  • 1998 Immunomodulation of Crohn’s disease by Interleukin-10 in THERAPEUTIC STRATEGIES FOR MODULATING THE INFLAMMATORY DISEASES
  • 1997-08 Pharmacodynamics of subcutaneous recombinant human interleukin‐10 in healthy volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1996-09 Clinical, hematologic, and immunologic effects of interleukin-10 in humans in JOURNAL OF CLINICAL IMMUNOLOGY
  • 1996-02 Pharmacodynamic Effects of Interferon ALFA‐2b in Healthy Volunteers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1996-02 Effect of food and postprandial state on the bioavailability of micronized progesterone in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1996-02 Effect of SCH 48461 on oral cholesterol absorption in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1996-02 Effect of food on the oral bioavailability of temozolomide, a new chemotherapeutic agent in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1995 A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production in INTERLEUKIN-10
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.417993.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.273335.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.469474.c", 
            "type": "Organization"
          }
        ], 
        "familyName": "Cutler", 
        "givenName": "David L", 
        "id": "sg:person.0673106361.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673106361.44"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_612.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0673106361.44'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0673106361.44'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0673106361.44'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0673106361.44'


     




    Preview window. Press ESC to close (or click here)


    ...